The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1132
June 10, 2002
View Complete Issue         Table of Contents 2019 
Triptorelin Pamoate (Trelstar)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Triptorelin Pamoate (Trelstar)
June 10, 2002 (Issue: 1132)
Two controlled-release formulations of triptorelin (trip toe rel' in) pamoate, an agonist analog of human luteinizing hormone-releasing hormone (LHRH), are now available in the US for parenteral treatment of advanced prostate cancer. Trelstar Depot...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Triptorelin Pamoate (Trelstar)
Article code: 1132a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.